Anemia In End Stage Renal Disease Study Testing And Investigational Drug Daprodustat Anemia Pill Vs. The Standard Of Care (Aranesp) Injections.
Posted Date: May 15, 2019
- Investigator: Shashi Kant
- Type of Study: Drug
The purpose of this study is to test how effective daprodustat (an investigational medicine which has not yet been approved by regulatory agencies such as the United States Food and Drug Administration (FDA)) is compared with epoetin alfa or darbepoetin alfa (which has been approved) (called EPO fro
Criteria:
Patients With End Stage Renal Disease Currently On Hemodialysis Or Peritoneal Dialysis For > 90 Days
Keywords:
Erythropoeisis Stimu, Anemia, Dialysis
For More Information:
Heather J Duncan, Phd
513-559-3362
heather.duncan@uc.edu